Prediction model for CD34 positive cell yield in peripheral blood stem cell collection on the fourth day after G-CSF administration in healthy donors
- 22 May 2013
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 98 (1) , 56-65
Abstract
Allogeneic peripheral blood stem cell transplantation (PBSCT) is an indispensable treatment option for hematological malignancy. The optimal collection day after granulocyte colony-stimulating factor (G-CSF) administration should be determined by peripheral blood pre-apheresis CD34 positive (CD34+) cell percentage. However, pre-apheresis CD34+ cell analysis is not available for most institutions in Japan. Prediction of the optimal collection day based on objective parameters, other than direct CD34+ cell count, is thus an important matter for investigation. To identify potential predictive factors, clinical parameters in 79 related donors who received allogeneic peripheral blood stem cell (PBSC) collection were analyzed. Eight factors were significantly correlated with the number of CD34+ cells per donor body weight on the fourth day (day 4) after G-CSF administration in univariate analysis. Using multi-regression analysis, we made a simple scoring system comprising age, sex, LDH on day 4 and RBC count at the baseline, which significantly predicted CD34+ cell yield (P = 0.048). This system allows us to determine the optimal PBSC collection day. When the score is 0 or 1 on day 4, starting apheresis on day 5 potentially helps avoiding the need for multiple harvests. Score 3 or 4 on day 4 is indicative of better performance if apheresis is started on day 4.Keywords
This publication has 31 references indexed in Scilit:
- Prediction of number of apheresis procedures necessary in healthy donors to attain minimally required peripheral blood CD34+ cellsTransfusion, 2009
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete RemissionJAMA, 2009
- Predictive parameters for granulocyte colony‐stimulating factor‐induced peripheral blood stem cell mobilizationJournal of Clinical Apheresis, 2008
- Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports projectBone Marrow Transplantation, 2007
- Factors associated with granulocyte colony‐stimulating factor‐induced peripheral blood stem cell yield in healthy donorsVox Sanguinis, 2005
- Immature granulocyte fraction in the peripheral blood is a practical indicator for mobilization of CD34+ cellsAmerican Journal of Hematology, 2004
- Peripheral blood circulating immature cell counts predict CD34+ cell yields in G‐CSF‐induced PBPC mobilization in healthy donorsTransfusion, 2004
- Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor ProgramBlood, 2004
- Management strategies for the hard-to-mobilize patientBone Marrow Transplantation, 1999
- Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cellsTransfusion, 1996